OMLYCLO FDA approval date

The FDA approved OMLYCLO on 7 Mar 2025.

FDA approval date
7 Mar 2025

Drug identity has not yet been verified against registry records

Also recorded as OMALIZUMAB-IGEC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-03-07DayOMLYCLOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761399", "applicant_as_listed_by_fda": "CELLTRION INC", "brand_names": ["OMLYCLO"], "active_ingredients": ["OMALIZUMAB-IGEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250307", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026